Memorial Sloan-kettering Cancer Center - Net Worth and Insider Trading
Memorial Sloan-kettering Cancer Center Net Worth
The estimated net worth of Memorial Sloan-kettering Cancer Center is at least $1 Million dollars as of 2024-06-10. Memorial Sloan-kettering Cancer Center is the 10% Owner of Actinium Pharmaceuticals Inc and owns about 156,984 shares of Actinium Pharmaceuticals Inc (ATNM) stock worth over $1 Million. Details can be seen in Memorial Sloan-kettering Cancer Center's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Memorial Sloan-kettering Cancer Center has not made any transactions after 2016-08-31 and currently still holds the listed stock(s).
Transaction Summary of Memorial Sloan-kettering Cancer Center
Memorial Sloan-kettering Cancer Center Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Memorial Sloan-kettering Cancer Center owns 1 companies in total, including Actinium Pharmaceuticals Inc (ATNM) .
Insider Ownership Summary of Memorial Sloan-kettering Cancer Center
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATNM | Actinium Pharmaceuticals Inc | 2016-08-31 | 10 percent owner |
Memorial Sloan-kettering Cancer Center Latest Holdings Summary
Memorial Sloan-kettering Cancer Center currently owns a total of 1 stock. Memorial Sloan-kettering Cancer Center owns 156,984 shares of Actinium Pharmaceuticals Inc (ATNM) as of August 31, 2016, with a value of $1 Million.
Latest Holdings of Memorial Sloan-kettering Cancer Center
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATNM | Actinium Pharmaceuticals Inc | 2016-08-31 | 156,984 | 8.12 | 1,274,710 |
Holding Weightings of Memorial Sloan-kettering Cancer Center
Memorial Sloan-kettering Cancer Center Form 4 Trading Tracker
According to the SEC Form 4 filings, Memorial Sloan-kettering Cancer Center has made a total of 0 transactions in Actinium Pharmaceuticals Inc (ATNM) over the past 5 years. The most-recent trade in Actinium Pharmaceuticals Inc is the sale of 6,431 shares on August 31, 2016, which brought Memorial Sloan-kettering Cancer Center around $353,056.
Insider Trading History of Memorial Sloan-kettering Cancer Center
- 1
Memorial Sloan-kettering Cancer Center Trading Performance
Memorial Sloan-kettering Cancer Center Ownership Network
Memorial Sloan-kettering Cancer Center Owned Company Details
What does Actinium Pharmaceuticals Inc do?
Who are the key executives at Actinium Pharmaceuticals Inc?
Memorial Sloan-kettering Cancer Center is the 10 percent owner of Actinium Pharmaceuticals Inc. Other key executives at Actinium Pharmaceuticals Inc include VP & Finance and Corporate Dev. Steve O'loughlin , Chief Scientific Officer Dale L. Ludwig , and Chief Commercial Officer Anil Kapur .
Actinium Pharmaceuticals Inc (ATNM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Actinium Pharmaceuticals Inc (ATNM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Actinium Pharmaceuticals Inc (ATNM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Actinium Pharmaceuticals Inc (ATNM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Actinium Pharmaceuticals Inc Insider Transactions
Memorial Sloan-kettering Cancer Center Mailing Address
Above is the net worth, insider trading, and ownership report for Memorial Sloan-kettering Cancer Center. You might contact Memorial Sloan-kettering Cancer Center via mailing address: 1275 York Ave., New York Ny 10065.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
